Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01011959 · ClinicalTrials.gov registry record · Phase 1

A Multiple-dose Study of the Safety and Tolerability of REGN88(SAR153191) in Rheumatoid Arthritis Subjects

A Phase 1 study of Rheumatoid Arthritis, sponsored by Regeneron Pharmaceuticals.

Completed
Registry status
Phase 1
Development phase
60
Enrollment target
20
Study locations

NCT01011959 is a Phase 1 study of Rheumatoid Arthritis that has completed, run by Regeneron Pharmaceuticals. The registered enrollment target is 60 participants, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (99% lower). The trial reports 20 study locations across 13 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01011959, a Phase 1 study of Rheumatoid Arthritis, has completed, sponsored by Regeneron Pharmaceuticals.

COMPLETED
Registry status
Phase 1
Development phase
60 participants
Enrollment target
20
Study locations

Study Summary

This is a randomized study of the safety and tolerability of multiple doses of REGN88 in rheumatoid arthritis patients who are receiving treatment with methotrexate.

Conditions Studied

Rheumatoid Arthritis

Interventions

  • BIOLOGICAL REGN88

Study Locations (20)

Florida

  • - Boca Raton
  • - Clearwater
  • - Daytona Beach
  • - Delray Beach
  • - Palm Harbor

Missouri

  • - Kalamzaoo
  • - St Louis

Ohio

  • - Cincinnati
  • - Toledo

South Carolina

  • - Greenville
  • - Orangeburg

California

  • - Santa Maria

Idaho

  • - Idaho Falls

Massachusetts

  • - Worcester

Michigan

  • - Lansing

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2008-12
Est. Completion 2009-08
Phase Phase 1

Sponsor

Regeneron Pharmaceuticals

280 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01011959

The ClinicalTrials.gov registry entry for NCT01011959 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (99% lower). The listed sponsor is Regeneron Pharmaceuticals, which has 280 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 1 intervention - of which REGN88 is the first listed.

NCT01011959 reports 20 study locations spanning 13 distinct geographic areas - top geographies include Florida, Missouri, Ohio.

Frequently Asked Questions

What is clinical trial NCT01011959 about?

NCT01011959 is a clinical study titled "A Multiple-dose Study of the Safety and Tolerability of REGN88(SAR153191) in Rheumatoid Arthritis Subjects". This is a randomized study of the safety and tolerability of multiple doses of REGN88 in rheumatoid arthritis patients who are receiving treatment with methotrexate.

What is the current status of trial NCT01011959?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 60 participants. The study started on 2008-12. Estimated completion is 2009-08.

What conditions does trial NCT01011959 study?

This clinical trial studies the following conditions: Rheumatoid Arthritis.

What interventions are being tested in trial NCT01011959?

The interventions under investigation include: REGN88 (BIOLOGICAL).

Who is sponsoring clinical trial NCT01011959?

This trial is sponsored by Regeneron Pharmaceuticals, which has 280 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01011959 being conducted?

This trial has 20 study locations across California, Florida, Idaho, Massachusetts, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Rheumatoid Arthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Rheumatoid Arthritis

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.